Dysregulation of gene expression in the artificial human trisomy cells of chromosome 8 associated with transformed cell phenotypes

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Nawata, Hisakatsu ^a   Kashino, Genro ^b   Tano, Keizo ^a   Daino, Kazuhiro ^c   Shimada, Yoshiya ^c   Kugoh, Hiroyuki ^d   Oshimura, Mitsuo ^d   Watanabe, Masami ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; ARTIFICIAL CELL; CELL ADHESION; CELL AGING; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOMAL INSTABILITY; CHROMOSOME 8; CONTROLLED STUDY; DIPLOIDY; FIBROBLAST; GENE DISRUPTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; TRISOMY; CONTACT INHIBITION; DNA DAMAGE; DNA MICROARRAY; GENETICS; METABOLISM; PATHOLOGY;

TRANSCRIPTOME;

ARTIFICIAL CELLS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 8; CONTACT INHIBITION; DIPLOIDY; DNA DAMAGE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; TRANSCRIPTOME; TRISOMY;

EID: 80053300903     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025319     Document Type: Article

References (52)

1. Ganmore I, Smooha G, Izraeli S, (2009) Constitutional aneuploidy and cancer predisposition. Hum Mol Genet 18: R84-93.
2. Weaver BAA, Cleveland DW, (2006) Does aneuploidy cause cancer? Current Opinion in Cell Biology 18: 658-667.
3. Hassold T, Hunt P, (2001) To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet 2: 280-291.
4. Williams BR, Prabhu VR, Hunter KE, Glazier CM, Whittaker CA, et al. (2008) Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells. Science 322: 703-709.
5. Upender MB, Habermann JK, McShane LM, Korn EL, Barrett JC, et al. (2004) Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res 64: 6941-6949.
6. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, et al. (2001) Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A 98: 1124-1129.
7. Shay JW, Wright WE, (2000) Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol 1: 72-76.
8. Hayflick L, Moorhead PS, (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
9. Fletcher JA, Naeem R, Xiao S, Corson JM, (1995) Chromosome aberrations in desmoid tumors trisomy 8 may be a predictor of recurrence. Cancer Genetics and Cytogenetics 79: 139-143.
10. Schofield DE, Fletcher JA, Grier HE, Yunis EJ, (1994) Fibrosarcoma in Infants and Children: Application of New Techniques. The American Journal of Surgical Pathology 18: 14-24.
11. Schofield DE, Yunis EJ, Fletcher JA, (1993) Chromosome aberrations in mesoblastic nephroma. Am J Pathol 143: 714-724.
12. Sankary S, Dickman PS, Wiener E, Robichaux W, Swaney WP, et al. (1993) Consistent numerical chromosome aberrations in congenital fibrosarcoma. Cancer Genetics and Cytogenetics 65: 152-156.
13. Doherty AM, Fisher EM, (2003) Microcell-mediated chromosome transfer (MMCT): small cells with huge potential. Mamm Genome 14: 583-592.
14. Fagotto F, Gumbiner BM, (1996) Cell Contact-Dependent Signaling. Developmental Biology 180: 445-454.
15. Perucho M, Goldfarb M, Shimizu K, Lama C, Fogh J, et al. (1981) Human-tumor-derived cell lines contain common and different transforming genes. Cell 27: 467-476.
16. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
17. Fernandez-Capetillo O, Chen H-T, Celeste A, Ward I, Romanienko PJ, et al. (2002) DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 4: 993-997.
18. Rappold I, Iwabuchi K, Date T, Chen J, (2001) Tumor Suppressor P53 Binding Protein 1 (53bp1) Is Involved in DNA Damage-Signaling Pathways. The Journal of Cell Biology 153: 613-620.
19. Schultz LB, Chehab NH, Malikzay A, Halazonetis TD, (2000) p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 151: 1381-1390.
20. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM, (1998) DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139. Journal of Biological Chemistry 273: 5858-5868.
21. Fenech M, (2000) The in vitro micronucleus technique. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 455: 81-95.
22. Solomon E, Borrow J, Goddard A, (1991) Chromosome aberrations and cancer. Science 254: 1153-1160.
23. Yang Z, Kodama S, Suzuki K, Watanabe M, (1998) Telomerase activity, telomere length, and chromosome aberrations in the extension of life span of human embryo cells induced by low-dose X-rays. J Radiat Res (Tokyo) 39 (1): 35-51.
24. Kodama S, Mori I, Roy K, Yang Z, Suzuki K, Watanabe M, (2001) Culture condition-dependent senescence-like growth arrest and immortalization in rodent embryo cells. Radiat Res 155 (1 Pt 2): 254-262.
25. Boffetta P, van der Hel O, Norppa H, Fabianova E, Fucic A, et al. (2007) Chromosomal Aberrations and Cancer Risk: Results of a Cohort Study from Central Europe. American Journal of Epidemiology 165: 36-43.
26. Meaburn KJ, Misteli T, (2007) Cell biology: Chromosome territories. Nature 445: 379-381.
27. Lanctot C, Cheutin T, Cremer M, Cavalli G, Cremer T, (2007) Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat Rev Genet 8: 104-115.
28. Fraser P, Bickmore W, (2007) Nuclear organization of the genome and the potential for gene regulation. Nature 447: 413-417.
29. Gasser SM, (2002) Visualizing Chromatin Dynamics in Interphase Nuclei. Science 296: 1412-1416.
30. Murakami Y, (2005) Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Science 96: 543-552.
31. Goto A, Niki T, Chi-pin L, Matsubara D, Murakami Y, et al. (2005) Loss of TSLC1 expression in lung adenocarcinoma: Relationships with histological subtypes, sex and prognostic significance. Cancer Science 96: 480-486.
32. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, et al. (2001) TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 27: 427-430.
33. Mao X, Seidlitz E, Truant R, Hitt M, Ghosh HP, (2004) Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth. Oncogene 23: 5632-5642.
34. Shingai T, Ikeda W, Kakunaga S, Morimoto K, Takekuni K, et al. (2003) Implications of Nectin-like Molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in Cell-Cell Adhesion and Transmembrane Protein Localization in Epithelial Cells. Journal of Biological Chemistry 278: 35421-35427.
35. Sakurai-Yageta M, Masuda M, Tsuboi Y, Ito A, Murakami Y, (2009) Tumor suppressor CADM1 is involved in epithelial cell structure. Biochemical and Biophysical Research Communications 390: 977-982.
36. Tsujiuchi T, Sugata E, Masaoka T, Onishi M, Fujii H, et al. (2007) Expression and DNA methylation patterns of Tslc1 and Dal-1 genes in hepatocellular carcinomas induced by N-nitrosodiethylamine in rats. Cancer Science 98: 943-948.
37. Shimizu K, Onishi M, Sugata E, Fujii H, Honoki K, et al. (2007) Aberrant DNA methylation of the 5′ upstream region of Tslc1 gene in hamster pancreatic tumors. Biochemical and Biophysical Research Communications 353: 522-526.
38. Heller G, Fong KM, Girard L, Seidl S, End-Pfutzenreuter A, et al. (2005) Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Oncogene 25: 959-968.
39. Ito T, Shimada Y, Hashimoto Y, Kaganoi J, Kan T, et al. (2003) Involvement of TSLC1 in Progression of Esophageal Squamous Cell Carcinoma. Cancer Research 63: 6320-6326.
40. Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, et al. (2003) Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. International Journal of Cancer 107: 53-59.
41. Algar EM, Kenney MT, Simms LA, Smith SI, Kida Y, et al. (1995) Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript. Hum Mutat 5: 221-227.
42. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, et al. (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778.
43. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, et al. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520.
44. Loeb D, Sukumar S, (2002) The Role of WT1 in Oncogenesis: Tumor Suppressor or Oncogene? International Journal of Hematology 76: 117-126.
45. Little M, Wells C, (1997) A clinical overview of WT1 gene mutations. Human Mutation 9: 209-225.
46. Rauscher F, (1993) The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. The FASEB Journal 7: 896-903.
47. Haber DA, Park S, Maheswaran S, Englert C, Re GG, et al. (1993) WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science 262: 2057-2059.
48. Coppes M, Campbell C, Williams B, (1993) The role of WT1 in Wilms tumorigenesis. The FASEB Journal 7: 886-895.
49. Huff V, (2011) Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer 11: 111-121.
50. Sugiyama H, (2010) WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol 40: 377-387.
51. Suzuki M, Yang Z, Nakano K, Yatagai F, Suzuki K, et al. (1998) Extension of in vitro life-span of gamma-irradiated human embryo cells accompanied by chromosome instability. J Radiat Res (Tokyo) 39: 203-213.
52. Kugoh H, Mitsuya K, Meguro M, Shigenami K, Schulz TC, Oshimura, (1999) Mouse A9 cells containing single human chromosomes for analysis of genomic imprinting. DNA Res 6: 165-172.